Fibrodysplasia Ossificans Progressiva (FOP)
Musculoskeletal·MeSH: Myositis Ossificans
Prevalence
0.1 / 100K
2 drugs in development·2 companies·1 clinical trial
Drug Pipeline by Phase
Phase 2(2)
Compare drugs
Frequently asked questions
How many drugs are in development for Fibrodysplasia Ossificans Progressiva (FOP)?
BioSniper tracks 2 drugs in development for Fibrodysplasia Ossificans Progressiva (FOP) across 2 companies.
How many clinical trials target Fibrodysplasia Ossificans Progressiva (FOP)?
There are 1 clinical trial targeting Fibrodysplasia Ossificans Progressiva (FOP) tracked by BioSniper.
What is the prevalence of Fibrodysplasia Ossificans Progressiva (FOP)?
The estimated prevalence of Fibrodysplasia Ossificans Progressiva (FOP) is approximately 0.1 per 100,000 population.
Deep-dive into Fibrodysplasia Ossificans Progressiva (FOP)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis